SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $325,237 | +31.1% | 1,662 | +13.8% | 0.02% | +18.8% |
| Q2 2020 | $248,083 | +51.4% | 1,460 | +2.8% | 0.02% | +14.3% |
| Q1 2020 | $163,840 | +1.9% | 1,420 | +0.9% | 0.01% | +27.3% |
| Q4 2019 | $160,764 | +24.4% | 1,407 | -7.0% | 0.01% | 0.0% |
| Q3 2019 | $129,210 | +33.9% | 1,513 | +8.5% | 0.01% | +37.5% |
| Q2 2019 | $96,479 | +2.9% | 1,394 | +8.9% | 0.01% | -11.1% |
| Q1 2019 | $93,747 | +26.2% | 1,280 | -2.4% | 0.01% | 0.0% |
| Q4 2018 | $74,281 | +6.2% | 1,311 | +44.5% | 0.01% | +12.5% |
| Q3 2018 | $69,948 | +18.6% | 907 | +2.1% | 0.01% | 0.0% |
| Q2 2018 | $58,954 | +65.2% | 888 | +30.2% | 0.01% | +60.0% |
| Q1 2018 | $35,696 | +86.4% | 682 | +90.5% | 0.01% | +66.7% |
| Q4 2017 | $19,153 | – | 358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |